 closure at
1 year

3 studies, 2 RCTs, one
observational (448 patients)

EVLA vs UGFS
(RR, 1.23; 95% CI, 1.11 to 1.37;
I2 Â¼ 0.00%)

Reintervention at
1 year

2 studies, 2 RCTs (740 patients) (RR, 0.51;